Drug provides relief to those with overactive bladder

Article

The FDA recently approved trospium (Sanctura, Indevus Pharmaceuticals/Odyssey Pharmaceuticals) for the treatment of OAB with symptoms of urge urinary incontinence, urgency, and urinary frequency. The product launch of trospium is expected to take place during the third quarter of 2004.

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Image Credit: jokekung - stock.adobe.com
Image Credit: gamelover - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.